We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Graves Disease Induced by Shed Antigens

By Biotechdaily staff writers
Posted on 01 Jul 2003
Researchers have found that the autoantibodies against the thyroid gland that cause the hyperthyroidism characteristic of Graves disease preferentially recognize an antigen that is cleaved from the thyroid stimulating hormone receptor (TSHR) and shed into the extracellular milieu. More...


Investigators at Cedars-Sinai Medical Center (Los Angeles, CA, USA) used a novel adenovirus-mediated animal model of Graves disease to show that goiter and hyperthyroidism occur to a much greater extent when the adenovirus expressed the free A subunit as opposed to a genetically modified TSHR that did not readily cleave into subunits. Non-cleaving glycoprotein hormone receptors did not generate functional autoantibodies. These findings were published in the June 16, 2003, issue of the Journal of Clinical Investigation.

The authors conclude, "These data show that shed A subunits induce or amplify the immune response leading to hyperthyroidism and provide a new insight into the etiology of Graves disease.” They also note, however, that while the data increase help to explain why autoantibodies arise to the TSHR, stimulate the thyroid, and result in Graves hperthyroidism, the mechanisms responsible for TSHR cleavage require further exploration.




Related Links:
Cedars-Sinai Medical Center

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Automatic Hematology Analyzer
CF9600
New
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
Urine Analyzer
respons® UDS100
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.